School of Biological Sciences


  1. Supplementary Material for: Allergen-Induced Increases in Interleukin-25 and Interleukin-25 Receptor Expression in Mature Eosinophils from Atopic Asthmatics

    Tang, W. (Creator), Smith, S. G. (Creator), Salter, B. (Creator), Oliveria, J. (Creator), Mitchell, P. (Creator), Nusca, G. (Creator), Howie, K. (Creator), Gauvreau, G. M. (Creator), O'Byrne, P. (Creator), Sehmi, R. (Creator), figshare , 29 Sep 2016, 10.6084/m9.figshare.3969144


  2. The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials

    O'Byrne, P. (Creator), Fitzgerald, J. (Creator), Zhong, N. S. (Creator), Bateman, E. D. (Creator), Barnes, P. J. (Creator), Keen, C. (Creator), Almqvist, G. (Creator), Pemberton, K. (Creator), Jorup, C. (Creator), Ivanov, S. (Creator), Reddel, H. K. (Creator), figshare , 10 Jan 2017, 10.6084/m9.figshare.c.3661703


  3. Patient-centred standards of care for adults with myositis

    Lilleker, J. (Creator), Gordon, P. (Creator), Lamb, J. (Creator), Lempp, H. (Creator), Cooper, R. (Creator), Roberts, M. (Creator), Jordan, P. (Creator), Chinoy, H. (Creator), figshare , 28 Nov 2017, 10.6084/m9.figshare.c.4041848


  4. Raw data for Figure 2C: HIDEMs and mesoangioblasts fail to induce T cell proliferation in vitro

    Li, O. (Creator), English, K. (Creator), Tonlorenzi, R. (Creator), Cossu, G. (Creator), Tedesco, F. S. (Creator), Wood, K. J. (Creator), figshare , 25 Jan 2013, 10.6084/m9.figshare.106724


  5. Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

    Jenkins, C. (Creator), Eriksson, G. (Creator), Bateman, E. D. (Creator), Reddel, H. K. (Creator), Sears, M. R. (Creator), Lindberg, M. (Creator), O'Byrne, P. (Creator), figshare , 20 Apr 2017, 10.6084/m9.figshare.c.3747731


  6. Supplementary material from "Secondary metabolite arsenal of an opportunistic pathogenic fungus"

    Bignell, E. (Creator), Cairns, T. C. (Creator), Throckmorton, K. (Creator), Nierman, W. C. (Creator), Keller, N. P. (Creator), figshare , 5 Oct 2016, 10.6084/m9.figshare.c.3493065


  7. Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

    O'Byrne, P. (Creator), Jacques, L. (Creator), Goldfrad, C. (Creator), Namhee, K. (Creator), Perrio, M. (Creator), Yates, L. J. (Creator), Busse, W. (Creator), figshare , 24 Nov 2016, 10.6084/m9.figshare.c.3628850


  8. Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa

    Hughes, D. (Creator), Giugliani, R. (Creator), Guffon, N. (Creator), Jones, S. (Creator), Mengel, K. (Creator), Parini, R. (Creator), Matousek, R. (Creator), Hawley, S. (Creator), Quartel, A. (Creator), figshare , 23 May 2017, 10.6084/m9.figshare.c.3786374


  9. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

    Wei, W. (Creator), Keogh, M. (Creator), Wilson, I. (Creator), Coxhead, J. (Creator), Ryan, S. (Creator), Rollinson, S. (Creator), Griffin, H. (Creator), Kurzawa-Akinibi, M. (Creator), Santibanez-Koref, M. (Creator), Talbot, K. (Creator), Turner, M. (Creator), McKenzie, C. A. (Creator), Troakes, C. (Creator), Attems, J. (Creator), Smith, C. (Creator), Al-Sarraj, S. (Creator), Morris, C. (Creator), Ansorge, O. (Creator), Pickering-Brown, S. (Creator), Ironside, J. (Creator), Chinnery, P. F. (Creator), figshare , 2 Feb 2017, 10.6084/m9.figshare.c.3681895


Return to faculty and school overview